All News Lavipharm S.A.

Equities

Delayed Athens S.E. Other stock markets 04:47:21 31/05/2024 pm IST			5-day change	1st Jan Change
0.91 ^EUR	-1.52%		-7.05%	+14.32%

28/02	Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	CI

Lavipharm S A : Annual Analysts Briefing	24/04	PU
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Lavipharm S A : ANNOUNCEMENT	11/12	PU
Lavipharm S A : enters into a new asset purchase agreement	11/12	PU
Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	11/12	CI
Lavipharm S A : Asset Purchase Agreement for Lavipharm	01/12	PU
Lavipharm S.A. signing of an asset purchase agreement to acquire Lonarid N and Lonalgal from Boehringer Ingelheim International GmbH.	01/12	CI
Lavipharm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	08/11	CI
Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	21/23/21	PU
Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	21/23/21	PU
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	21/23/21	CI
Lavipharm S A : Annual Shareholders’ Meeting	06/23/06	PU
Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	06/23/06	PU
Lavipharm S.A.(ATSE:LAVI) added to ATHEX Composite Index	21/23/21	CI
Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	26/23/26	PU
Lavipharm S A : Results Q1 2023	04/23/04	PU
Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/23/04	CI
Lavipharm S A : AMENDMENT OF THE 2023 FINANCIAL CALENDAR	27/23/27	PU
Lavipharm S A : ANNOUNCEMENT	28/23/28	PU
Lavipharm S A : Announcement 1668/2023	15/23/15	PU

No results for this search